BioCentury | Jul 21, 2014
Clinical News

ImStem Biotechnology preclinical data

...and funding for Phase I trials of hES-MSCs but could not be reached for details. ImStem Biotechnology Inc....
BioCentury | Sep 2, 2013
Financial News

ImStem Biotechnology completes venture financing

ImStem Biotechnology Inc. , Farmington, Conn. Business: Gene/Cell therapy, Cardiovascular, Autoimmune Date completed: 8/20/13 Type: Venture financing Raised: $75,000 Investors: Connecticut Innovations Note: ImStem received $75,000 of an expected $150,000 financing. WIR Staff...
Items per page:
1 - 2 of 2
BioCentury | Jul 21, 2014
Clinical News

ImStem Biotechnology preclinical data

...and funding for Phase I trials of hES-MSCs but could not be reached for details. ImStem Biotechnology Inc....
BioCentury | Sep 2, 2013
Financial News

ImStem Biotechnology completes venture financing

ImStem Biotechnology Inc. , Farmington, Conn. Business: Gene/Cell therapy, Cardiovascular, Autoimmune Date completed: 8/20/13 Type: Venture financing Raised: $75,000 Investors: Connecticut Innovations Note: ImStem received $75,000 of an expected $150,000 financing. WIR Staff...
Items per page:
1 - 2 of 2